Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
Clinical trial NCT04363359 · COMPLETED
Trial details
- NCT number
- NCT04363359
- Sponsor
- Shanghai Institute Of Biological Products
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2021-09-14
- Enrollment
- 1980
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.